Pablo Conesa Zamora

Title: Pablo Conesa Zamora: Innovator in Cancer Treatment

Introduction

Pablo Conesa Zamora is a notable inventor based in Murcia, Spain. He has made significant contributions to the field of cancer treatment through his innovative research and patenting efforts. His work primarily focuses on the use of Imipramine as an inhibitor of Fascin1 overexpression, which is associated with various types of cancer.

Latest Patents

Pablo Conesa Zamora holds a patent for "Imipramine for use as an inhibitor of Fascin1 overexpression." This invention specifically addresses the overexpression of Fascin1 in relation to cancer, with a particular emphasis on colorectal cancer. The patent outlines a method for treating cancer mediated by Fascin1, which involves administering an effective amount of Imipramine to patients in need.

Career Highlights

Throughout his career, Pablo has worked with esteemed organizations such as Fundación Universitaria San Antonio and Fundación para la Formación e Investigación Sanitarias. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Pablo has collaborated with notable colleagues, including Horacio Perez Sanchez and Irene Luque Fernández. These partnerships have enriched his research and fostered a collaborative environment for innovation.

Conclusion

Pablo Conesa Zamora is a dedicated inventor whose work in cancer treatment through the use of Imipramine showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against cancer, particularly colorectal cancer.